Usted buscó: somatropinom (Esloveno - Inglés)

zdravljenjem s somatropinom.
treatment with somatropin.

s somatropinom in med njim.
somatropin.

so jih zdravili s somatropinom.
with somatropin.

med zdravljenjem s somatropinom se bo
your blood glucose values will have

zdravljenja s somatropinom in med njim.
somatropin.

zdravljenje s somatropinom je dolgoročna terapija.
treatment with somatropin is a long-term therapy.

vzročne povezave z zdravljenjem s somatropinom niso ugotovili.
a causal relationship to somatropin therapy has not been established.

obe vrednosti se po zdravljenju s somatropinom hitro zvečata.
both are rapidly increased after treatment with somatropin.

ob presaditvi ledvic je treba zdravljenje s somatropinom prekiniti.
somatropin treatment should be stopped at kidney transplantation.

zato je treba med zdravljenjem s somatropinom spremljati znake skolioze.
therefore, signs of scoliosis should be monitored during treatment with somatropin.

v zgodnji fazi zdravljenja s somatropinom so opazili blag in prehoden edem.
mild and transient oedema was observed early during the course of treatment with somatropin.

na podlagi teh informacij se ti bolniki ne smejo zdraviti s somatropinom.
based on this information, these types of patients should not be treated with somatropin.

mišična moč in telesna zmogljivost se izboljšata po dolgotrajnem zdravljenju s somatropinom.
muscle strength and physical exercise capacity are improved after long-term treatment with somatropin.

zdravljenje s somatropinom pri otrocih in mladostnikih naj se nadaljuje do zapiranja epifiz.
somatropin therapy should be continued in children and adolescents until their epiphysis are closed.

izkušnje z zdravljenjem s somatropinom pri bolnikih, starih nad 60 let, so skope.
experience of somatropin treatment in patients above 60 years of age is limited.

po uvedbi zdravljenja s somatropinom potrebujejo nekateri bolniki nadomestno zdravljenje s ščitničnim hormonom.
after starting somatropin treatment some patients may need to start thyroid hormone replacement.

prekinitev ali zgodnje končanje zdravljenja s somatropinom lahko poslabša uspeh zdravljenja z rastnim hormonom.
a disruption or early ending of the treatment with somatropin may impair the success of the growth hormone therapy.

izkušnje s podaljšanim zdravljenjem (več kot 5 let) s somatropinom pri odraslih so skope.
experience of prolonged treatment (over 5 years) with somatropin in adults is limited.

vsakega otroka, pri katerem se med zdravljenjem s somatropinom pojavi šepanje, je treba klinično pregledati.
any child with the onset of a limp during growth hormone therapy should be evaluated.

bolnike, ki zaradi sladkorne bolezni jemljejo insulin, je treba med zdravljenjem s somatropinom skrbno spremljati.
patients taking insulin for diabetes mellitus should be carefully monitored during treatment with somatropin.